May 26, 2025

Abbott Laboratories (ABT) Stock Analysis: Exploring a 7% Potential Upside in the Healthcare Giant

Abbott Laboratories (NYSE: ABT), a titan in the healthcare industry, continues to capture the attention of investors with its robust operations and promising market position. With..

Corcept Therapeutics (CORT) Stock Analysis: A Look at Its 75.69% Potential Upside and Promising Pipeline

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology sector, is captivating investor attention with its ambitious clinical pipeline and impressive potential upside. With a..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a Competitive Diagnostics Landscape with 11.78% Upside Potential

Mettler-Toledo International, Inc. (NYSE: MTD) is a key player in the Healthcare sector, particularly within the Diagnostics & Research industry. Headquartered in Columbus, Ohio, the company..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating the 52-Week High and Future Prospects

Regencell Bioscience Holdings Limited (NASDAQ: RGC) has recently captured the attention of investors as it reached a staggering 52-week high of $560.00. This Hong Kong-based company..

RadNet, Inc. (RDNT) Investor Outlook: Analyzing a 27.19% Upside Potential

In the ever-evolving landscape of healthcare diagnostics, RadNet, Inc. (NASDAQ: RDNT) stands out as a formidable player. With a market capitalization of $4.25 billion, this Los..

United Therapeutics Corporation (UTHR) Stock Analysis: Unlocking a 26% Potential Upside with Robust Growth

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, as a frontrunner in developing innovative..

Moderna, Inc. (MRNA) Stock Analysis: Exploring an 81.63% Potential Upside Amidst Financial Challenges

As investors navigate the complex landscape of biotechnology stocks, Moderna, Inc. (NASDAQ: MRNA) stands out as a company with considerable potential upside, currently pegged at 81.63%..

Incyte Corporation (INCY): Analyst Consensus and Growth Potential in the Biotech Sector

In the fast-evolving landscape of biotechnology, Incyte Corporation (NASDAQ: INCY) stands out with a robust pipeline of therapeutics and a solid market presence. With a market..

Chemed Corp (CHE) Stock Analysis: Healthcare Leader with Nearly 19% Potential Upside

Investors eyeing the healthcare sector should take a closer look at Chemed Corp (NYSE: CHE), a robust player in the medical care facilities industry. With a..

Bio-Techne Corp (TECH) Stock Analysis: A Closer Look at Its 49.88% Potential Upside

Bio-Techne Corporation (NASDAQ: TECH) is catching the attention of investors with a potential upside of 49.88%, as indicated by the latest analyst targets. As a key..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking the 286% Potential Upside for Investors

Vaxcyte, Inc. (NASDAQ: PCVX) is capturing the attention of investors with its significant potential upside of 286.45%. This clinical-stage biotechnology company, headquartered in San Carlos, California,..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 39% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV) stands as a formidable player in the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of..

Quest Diagnostics (DGX) Stock Analysis: Uncovering a 7.41% Upside Potential for Investors

Quest Diagnostics Incorporated (NYSE: DGX) stands as a robust player within the healthcare sector, specializing in diagnostics and research. With a market capitalization of $19.12 billion,..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 22.75% Potential Upside in Healthcare

Option Care Health, Inc. (NASDAQ: OPCH), a prominent name in the healthcare sector, operates within the medical care facilities industry in the United States. With a..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 22.48% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN) is carving a niche in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Piombino Dese, Italy,..

Alcon Inc. (ALC) Stock Analysis: Exploring a 21.66% Upside Potential in the Eye Care Sector

Alcon Inc. (NYSE: ALC), a leading player in the healthcare sector, specifically within the medical instruments and supplies industry, is garnering attention for its strong market..

Becton, Dickinson and Company (BDX) Stock Analysis: Insights on a 30% Potential Upside

For individual investors with a keen eye on the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) stands out as a formidable player in the medical..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a 41.88% Potential Upside

As individual investors search for opportunities within the dynamic healthcare sector, Telix Pharmaceuticals Limited (ASX: TLX) emerges as a compelling prospect. This Australian biotechnology company, with..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A 32.63% Upside with Strong Buy Ratings

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is catching the eye of investors with a compelling 32.63% potential upside, making it a noteworthy consideration for those looking into..

Globus Medical, Inc. (GMED) Stock Analysis: A 44% Upside Potential Ignites Investor Interest

In the ever-evolving landscape of healthcare, Globus Medical, Inc. (NYSE: GMED) has carved a significant niche with its innovative medical devices, focusing primarily on musculoskeletal solutions...

Search

Funds

May 26, 2025

Search

Funds

May 26, 2025

FTSE 100

Funds